Simplex Trading’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-34,278
Closed -$993K 9004
2025
Q4
$993K Sell
34,278
-110,406
-76% -$3.31M ﹤0.01% 2612
2025
Q3
$4.02M Buy
144,684
+106,236
+276% +$2.68M ﹤0.01% 1674
2025
Q2
$936K Buy
+38,448
New +$842K ﹤0.01% 2848
2023
Q3
Sell
-2,102
Closed -$71K 8600
2023
Q2
$71K Buy
2,102
+2,002
+2,002% +$62.9K ﹤0.01% 5466
2023
Q1
$3K Sell
100
-3,300
-97% -$102K ﹤0.01% 8268
2022
Q4
$95K Sell
3,400
-40,966
-92% -$1.3M ﹤0.01% 5140
2022
Q3
$1.46M Buy
44,366
+41,266
+1,331% +$1.51M ﹤0.01% 2265
2022
Q2
$97K Buy
3,100
+2,100
+210% +$73.4K ﹤0.01% 5584
2022
Q1
$45K Sell
1,000
-1,200
-55% -$57.2K ﹤0.01% 7268
2021
Q4
$134K Buy
+2,200
New +$152K ﹤0.01% 5776
2021
Q2
Sell
-27,828
Closed -$2.47M 9986
2021
Q1
$2.47M Buy
27,828
+18,815
+209% +$1.87M ﹤0.01% 1396
2020
Q4
$840K Sell
9,013
-8,828
-49% -$703K ﹤0.01% 2780
2020
Q3
$1.14M Buy
+17,841
New +$1.05M ﹤0.01% 2094

Other funds holding ARKG

Simplex Trading's ARKG Position: Q1 2026 in Review

Simplex Trading sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2026, closing a stake of 34,278 shares — an estimated $993K sold.

Simplex Trading first reported a position in ARKG in Q3 2020 and held it in 13 quarters. The position peaked at $4.02M in Q3 2025. 218 funds tracked by Wall St. Rank hold ARKG as of Q1 2026.

  • Simplex Trading reported no remaining ARK Genomic Revolution ETF position as of Q1 2026 after selling out during the quarter.
  • Simplex Trading sold 34,278 ARK Genomic Revolution ETF shares in Q1 2026, an estimated $993K.
  • Simplex Trading first reported a position in ARK Genomic Revolution ETF in Q3 2020 and held it in 13 quarters.
  • Simplex Trading's ARK Genomic Revolution ETF position peaked at $4.02M in Q3 2025.
  • 218 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.